KBC Group NV Has $4.95 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

KBC Group NV raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 80.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 12,397 shares of the biotechnology company’s stock after buying an additional 5,532 shares during the period. KBC Group NV’s holdings in Axon Enterprise were worth $4,954,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Empowered Funds LLC acquired a new stake in Axon Enterprise during the 1st quarter valued at $340,000. Vanguard Group Inc. grew its holdings in shares of Axon Enterprise by 2.7% during the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after purchasing an additional 212,401 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in shares of Axon Enterprise in the first quarter valued at $2,137,000. Edgestream Partners L.P. bought a new position in shares of Axon Enterprise in the first quarter valued at about $1,043,000. Finally, Covestor Ltd lifted its position in Axon Enterprise by 18.4% during the 1st quarter. Covestor Ltd now owns 444 shares of the biotechnology company’s stock worth $139,000 after buying an additional 69 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Craig Hallum boosted their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Barclays upped their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. JMP Securities lifted their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Finally, Needham & Company LLC upped their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Stock Down 0.9 %

Shares of NASDAQ:AXON opened at $599.35 on Monday. The company has a 50 day moving average price of $438.79 and a two-hundred day moving average price of $357.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market capitalization of $45.70 billion, a PE ratio of 154.87, a PEG ratio of 15.05 and a beta of 0.94. Axon Enterprise, Inc. has a 52 week low of $220.78 and a 52 week high of $624.84.

Insider Activity at Axon Enterprise

In related news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. This represents a 2.59 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now owns 154,394 shares in the company, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 411,006 shares of company stock worth $161,360,618 in the last quarter. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.